Tech Company Financing Transactions

Verana Health Funding Round

Verana Health closed a $150 million Series E investment round on 1/25/2022. Backers included Johnson & Johnson Development Corporation, Novo Ventures and Breyer Capital.

Transaction Overview

Company Name
Verana Health
Announced On
1/25/2022
Transaction Type
Venture Equity
Amount
$150,000,000
Round
Series E
Investors

Johnson & Johnson Development Corporation (Lead Investor)

Novo Ventures (Lead Investor) (Jeffrey Low)

Breyer Capital

Casdin Capital

GV (Krishna Yeshwant)

private investors (Brook Byers)

Merck Global Health Innovation Fund

Transformational Healthcare Venture Capital

Proceeds Purpose
Verana Health plans to use the proceeds of the investment to advance its life sciences product and service strategy across the drug lifecycle, further enhance its value proposition to healthcare providers participating in its real-world data network, and expand its data footprint through medical society and strategic partnerships.

Company Information

Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
600 Harrison St. 250
San Francisco, CA 94107
USA
Phone
(650) 223-5560
Website
www.veranahealth.com
Email Address
[email protected]
Overview
Verana Health exists to improve patient lives by accelerating healthcare innovation through data insights. Our team has a deep understanding of the barriers to innovation through decades of experience working with and within life science and healthcare data companies.
Profile
Verana Health LinkedIn Company Profile
Social Media
Verana Health Company Twitter Account
Company News
Verana Health News
Facebook
Verana Health on Facebook
YouTube
Verana Health on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Miki Kapoor
  Miki Kapoor LinkedIn Profile  Miki Kapoor Twitter Account  Miki Kapoor News  Miki Kapoor on Facebook
Chief Financial Officer
Marie Piche
  Marie Piche LinkedIn Profile  Marie Piche Twitter Account  Marie Piche News  Marie Piche on Facebook
VP - Bus. Development
Donald Butler
  Donald Butler LinkedIn Profile  Donald Butler Twitter Account  Donald Butler News  Donald Butler on Facebook
VP - Bus. Development
Hylton Kalvaria
  Hylton Kalvaria LinkedIn Profile  Hylton Kalvaria Twitter Account  Hylton Kalvaria News  Hylton Kalvaria on Facebook
VP - Engineering
Nitin Karandikar
  Nitin Karandikar LinkedIn Profile  Nitin Karandikar Twitter Account  Nitin Karandikar News  Nitin Karandikar on Facebook
VP - General Counsel
Marc Berger
  Marc Berger LinkedIn Profile  Marc Berger Twitter Account  Marc Berger News  Marc Berger on Facebook
VP - Human Resources
Ellenmarie Rhone
  Ellenmarie Rhone LinkedIn Profile  Ellenmarie Rhone Twitter Account  Ellenmarie Rhone News  Ellenmarie Rhone on Facebook
VP - Marketing
Ritu Tandon
  Ritu Tandon LinkedIn Profile  Ritu Tandon Twitter Account  Ritu Tandon News  Ritu Tandon on Facebook
VP - Product Management
Karim Damji
  Karim Damji LinkedIn Profile  Karim Damji Twitter Account  Karim Damji News  Karim Damji on Facebook

 

 

Browse more venture capital transactions:

Prev: 1/25/2022: Observable venture capital transaction
Next: 1/25/2022: Vangst venture capital transaction

 

Share this article

 

About Our Venture Capital Transactions Database

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.